Ischemic Stroke with Protein S Deficiency Treated by Apixaban.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 12 11 2019
revised: 03 12 2019
accepted: 16 12 2019
pubmed: 17 1 2020
medline: 21 7 2020
entrez: 17 1 2020
Statut: ppublish

Résumé

A 57-year-old man with atherosclerosis obliterans was admitted with sudden-onset sensory aphasia and right hemiparesis. Brain MRI revealed acute cerebral infarctions in the left temporal lobe and magnetic resonance angiography showed occlusion of the posterior branch of the left middle cerebral artery. Transesophageal echocardiography and ultrasonography respectively confirmed a patent foramen ovale and deep vein thrombosis in the bilateral femoral veins. Blood findings showed low protein S antigen, low protein S activity, and a missense mutation of the PROS 1 gene. The administration of apixaban 10 mg BID prevented ischemic stroke recurrence and decreased the deep vein thrombosis. These outcomes indicated that apixaban may be alternative to warfarin for the secondary prevention of ischemic stroke in a patient with a protein S deficiency.

Identifiants

pubmed: 31941580
pii: S1052-3057(19)30713-X
doi: 10.1016/j.jstrokecerebrovasdis.2019.104608
pii:
doi:

Substances chimiques

Calcium-Binding Proteins 0
Factor Xa Inhibitors 0
PROS1 protein, human 0
Protein S 0
Pyrazoles 0
Pyridones 0
apixaban 3Z9Y7UWC1J

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

104608

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Ikkei Ohashi (I)

Division of Cerebrovascular Medicine and Neurology, National Hospitalization Organization, Kyushu Medical Centre, Japan; Department of Neurology, Sapporo Medical University School of Medicine, Japan.

Shinichi Wada (S)

Division of Cerebrovascular Medicine and Neurology, National Hospitalization Organization, Kyushu Medical Centre, Japan. Electronic address: ichi_basstrombone@yahoo.co.jp.

Fumitaka Yoshino (F)

Division of Cerebrovascular Medicine and Neurology, National Hospitalization Organization, Kyushu Medical Centre, Japan.

Takahiro Kuwashiro (T)

Division of Cerebrovascular Medicine and Neurology, National Hospitalization Organization, Kyushu Medical Centre, Japan.

Shinya Matsumoto (S)

Department of Clinical Chemistry and Laboratory Medicine, Graduates School of Medical Sciences, Kyushu University, Japan.

Taeko Hotta (T)

Department of Clinical Chemistry and Laboratory Medicine, Graduates School of Medical Sciences, Kyushu University, Japan.

Dongchong Kang (D)

Department of Clinical Chemistry and Laboratory Medicine, Graduates School of Medical Sciences, Kyushu University, Japan.

Yasushi Okada (Y)

Division of Cerebrovascular Medicine and Neurology, National Hospitalization Organization, Kyushu Medical Centre, Japan.

Shun Shimohama (S)

Department of Neurology, Sapporo Medical University School of Medicine, Japan.

Masahiro Yasaka (M)

Division of Cerebrovascular Medicine and Neurology, National Hospitalization Organization, Kyushu Medical Centre, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH